Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Simpson-Golabi-Behmel syndrome 1Recurrence 1Hepatoblastoma 1Carcinoma, Hepatocellular 1Advanced or Metastatic HCC 1

Interventions

Cyclophosphamide 4Granulocyte Colony-Stimulating Factor 3Filgrastim 3fludarabine 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Mesna 2Melphalan 2Etoposide 2Busulfan 2sargramostim 1regorafenib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1fludarabine phosphate 1codrituzumab 1Vorinostat 1Vincristine 1Topotecan 1Temozolomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Irinotecan 1Ifosfamide 1Gemcitabine 1Carboplatin 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hepatoblastoma × codrituzumab × Clear all
NCT04928677 2026-02-17

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
50 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Recurrence, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡